Compare
2 stocks, side by sideRelative performance · rebased to 100
ALNYRPRX
Pair ratio · ALNY ÷ RPRXRelative value, rich or cheap vs their own history
The price ratio ALNY ÷ RPRX with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| ALNYAlnylam Pharmaceuticals, Inc. | RPRXRoyalty Pharma plc | |
|---|---|---|
| Smart Score | 8/10 | 7/10 |
| Price | $293.17 | $54.69 |
| 1 month | -0.79% | +1.5% |
| 1 year | -9.8% | +55% |
| 5 year | +70% | +39% |
| P/E (TTM) | 67.8 | 29.3 |
| P/E vs sector | +115% | -7% |
| Market cap | $39.1B | $31.5B |
| Sector | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.